324 related articles for article (PubMed ID: 20964814)
1. Planning for the next influenza H1N1 season: a modelling study.
Carrat F; Pelat C; Levy-Bruhl D; Bonmarin I; Lapidus N
BMC Infect Dis; 2010 Oct; 10():301. PubMed ID: 20964814
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.
Yang P; Zhang L; Shi W; Lu G; Cui S; Peng X; Zhang D; Liu Y; Liang H; Pang X; Wang Q
Influenza Other Respir Viruses; 2012 Nov; 6(6):381-8. PubMed ID: 22212858
[TBL] [Abstract][Full Text] [Related]
3. Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.
Simpson CR; Ritchie LD; Robertson C; Sheikh A; McMenamin J
Health Technol Assess; 2010 Jul; 14(34):313-46. PubMed ID: 20630126
[TBL] [Abstract][Full Text] [Related]
4. Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season.
Weil-Olivier C; Lina B
Vaccine; 2011 Sep; 29(40):7075-9. PubMed ID: 21777639
[TBL] [Abstract][Full Text] [Related]
5. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11.
Pebody R; Hardelid P; Fleming D; McMenamin J; Andrews N; Robertson C; Thomas D; Sebastianpillai P; Ellis J; Carman W; Wreghitt T; Zambon M; Watson J
Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329644
[TBL] [Abstract][Full Text] [Related]
7. Trends in seasonal influenza vaccine coverage of target groups in France, 2006/07 to 2015/16: Impact of recommendations and 2009 influenza A(H1N1) pandemic.
Verger P; Fressard L; Cortaredona S; Lévy-Bruhl D; Loulergue P; Galtier F; Bocquier A
Euro Surveill; 2018 Nov; 23(48):. PubMed ID: 30514414
[TBL] [Abstract][Full Text] [Related]
8. Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9.
Mathews JD; McBryde ES; McVernon J; Pallaghy PK; McCaw JM
BMC Infect Dis; 2010 May; 10():128. PubMed ID: 20497585
[TBL] [Abstract][Full Text] [Related]
9. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
[TBL] [Abstract][Full Text] [Related]
10. Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated.
Ohmit SE; Petrie JG; Malosh RE; Johnson E; Truscon R; Aaron B; Martens C; Cheng C; Fry AM; Monto AS
J Infect Dis; 2016 Apr; 213(8):1229-36. PubMed ID: 26597255
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
12. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
[TBL] [Abstract][Full Text] [Related]
13. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.
Hardelid P; Fleming DM; McMenamin J; Andrews N; Robertson C; SebastianPillai P; Ellis J; Carman W; Wreghitt T; Watson JM; Pebody RG
Euro Surveill; 2011 Jan; 16(2):. PubMed ID: 21251487
[TBL] [Abstract][Full Text] [Related]
15. Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.
von Kries R; Weiss S; Falkenhorst G; Wirth S; Kaiser P; Huppertz HI; Tenenbaum T; Schroten H; Streng A; Liese J; Shai S; Niehues T; Girschick H; Kuscher E; Sauerbrey A; Peters J; Wirsing von König CH; Rückinger S; Hampl W; Michel D; Mertens T
PLoS One; 2011; 6(9):e23955. PubMed ID: 21915270
[TBL] [Abstract][Full Text] [Related]
16. Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey.
Vaux S; Van Cauteren D; Guthmann JP; Le Strat Y; Vaillant V; de Valk H; Lévy-Bruhl D
BMC Public Health; 2011 Jan; 11():30. PubMed ID: 21226919
[TBL] [Abstract][Full Text] [Related]
17. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
[TBL] [Abstract][Full Text] [Related]
18. Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination.
Fell DB; Wilson K; Ducharme R; Hawken S; Sprague AE; Kwong JC; Smith G; Wen SW; Walker MC
PLoS One; 2016; 11(8):e0160342. PubMed ID: 27486858
[TBL] [Abstract][Full Text] [Related]
19. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
